SCHEMBL2298645

SCHEMBL2298645

C[C@@](CC(=O)O)(c1ccccc1)n1cnc2cc(NC(=O)Nc3ccccc3)ccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.56
RAB9A P51151 9/20 0.56
SMN1; SMN2 Q16637 4/20 0.48
MAPT P10636 2/20 0.48
AURKA O14965 1/20 0.47
KDR P35968 1/20 0.47
AURKB Q96GD4 1/20 0.47
NR1I2 O75469 1/20 0.46
HPGD P15428 1/20 0.46
LMNA P02545 1/20 0.46
KMT2A Q03164 2/20 0.45
IDH1 O75874 1/20 0.45
TP53 P04637 1/20 0.44
THRB P10828 1/20 0.44
GAA P10253 1/20 0.44
RECQL P46063 1/20 0.44
MEN1 O00255 1/20 0.43
MAPK13 O15264 1/20 0.43
MAPK12 P53778 1/20 0.43
MAPK11 Q15759 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2295166 0.81 FGFR1 (0.46) NPC1RAB9ASMN1; SMN2MAPTHPGD
SCHEMBL2296252 0.70 NR1I2 (0.47) NPC1RAB9ASMN1; SMN2MAPTAURKA
SCHEMBL2296670 0.70 NR1I2 (0.47) NPC1RAB9ASMN1; SMN2MAPTAURKA
SCHEMBL5301051 0.68 AURKA (0.47) NPC1RAB9ASMN1; SMN2MAPTAURKA
SCHEMBL2298641 0.67 NR1I2 (0.44) NPC1RAB9ASMN1; SMN2MAPTNR1I2
SCHEMBL2298649 0.67 RAB9A (0.47) NPC1RAB9ASMN1; SMN2MAPTNR1I2
SCHEMBL2542625 0.67 NPC1 (0.47) NPC1RAB9ASMN1; SMN2MAPTHPGD
SCHEMBL2298534 0.67 EGLN3 (0.45) NPC1RAB9ASMN1; SMN2MAPTHPGD
SCHEMBL4372973 0.67 NPC1 (0.50) NPC1RAB9ASMN1; SMN2MAPTAURKA
SCHEMBL12421967 0.67 NR1I2 (0.45) NPC1RAB9ASMN1; SMN2MAPTAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003806-B2 Integrin antagonists useful as anticancer agents OSI Pharmaceuticals, LLC (US) 2011-08-23 US disclosed